SPL 0.00% 9.7¢ starpharma holdings limited

SPL Nasal Spray Competition from Ena Respiratory, page-9

  1. 55 Posts.
    lightbulb Created with Sketch. 101
    I came across the following article in The Guardian UK newspaper this morning. Ena Respiratory is certainly managing to generate international exposure in the media over their proposed nasal spray. Have not been able to find any reference in the international mainstream media re SPL's SPL7013 nasal spray.

    https://www.theguardian.com/world/2020/sep/28/scientists-work-on-nasal-spray-that-could-stop-covid-virus-replicating

    SPL are in a rather unique position and should be first to market which will benefit all SH's, however the great beneficiaries will be the frontline health workers, teachers, retail workers, the vulnerable, and anyone who has regular contact with other people. The current sense of urgency and focus is clearly evident, looking forward to further developments/announcements from SPL.


 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
0.000(0.00%)
Mkt cap ! $40.00M
Open High Low Value Volume
9.8¢ 10.5¢ 9.6¢ $210.8K 2.098M

Buyers (Bids)

No. Vol. Price($)
1 30408 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 3523 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.